Lettmann Jason bought ALXO
September 17, 2025 · Form 4 insider transaction
Lettmann Jason bought 71,163 shares of ALX Oncology Holdings Inc. at $1.08 per share, a transaction worth $76.9K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
71,163
Price
$1.08
Total value
$76.9K
InsiderLettmann Jason
RoleOfficer, Director
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateSeptember 17, 2025
Filing dateSeptember 18, 2025
Shares owned after305,121
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.05 to $1.09, inclusive.